Aurora Cannabis (ACB) Depreciation & Amortization (CF) (2017 - 2025)
Aurora Cannabis (ACB) posted quarterly Depreciation & Amortization (CF) of $1.4 million for Q1 2025, down 75.28% year-over-year from $5.6 million in Q1 2024, and down 63.49% quarter-over-quarter from $3.8 million in Q4 2024.
Aurora Cannabis (ACB) Depreciation & Amortization (CF) (2017 - 2025) Analysis & Trends
Aurora Cannabis (ACB) has reported Depreciation & Amortization (CF) for 9 consecutive years, with $1.4 million the latest figure, recorded in Q1 2025.
- In Q1 2025, Depreciation & Amortization (CF) fell 75.28% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $1.4 million (down 91.99% YoY), while the FY2026 annual figure was $9.8 million, down 25.04% from the prior year.
- Depreciation & Amortization (CF) slipped to $1.4 million in Q1 2025 per ACB's latest filing, from $3.8 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $24.6 million in Q4 2022 and bottomed at $1.4 million in Q1 2025.
- Historically, Depreciation & Amortization (CF) has averaged $9.6 million across 5 years, with a median of $5.7 million in 2021.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) surged 87.03% — and 2023, when it tumbled 77.75%.
- Aurora Cannabis' Depreciation & Amortization (CF) stood at $14.0 million in 2021, then soared by 76.3% to $24.6 million in 2022, then sank by 77.75% to $5.5 million in 2023, then sank by 30.7% to $3.8 million in 2024, then plunged by 63.49% to $1.4 million in 2025.
- Business Quant data shows ACB's Depreciation & Amortization (CF) at $1.4 million in Q1 2025, $3.8 million in Q4 2024, and $3.8 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Aurora Cannabis | 243.01 Mn | 170.70 Mn | 25.75 Mn | 2.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.39 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 3.80 Mn |
| Dec 31, 2024 | 3.80 Mn |
| Sep 30, 2024 | 3.79 Mn |
| Sep 30, 2024 | 3.79 Mn |
| Jun 30, 2024 | 4.12 Mn |
| Jun 30, 2024 | 4.12 Mn |
| Mar 31, 2024 | 5.61 Mn |
| Mar 31, 2024 | 5.61 Mn |
| Dec 31, 2023 | 5.48 Mn |
| Dec 31, 2023 | 5.48 Mn |
| Sep 30, 2023 | 5.41 Mn |
| Sep 30, 2023 | 5.41 Mn |
| Dec 31, 2022 | 24.64 Mn |
| Dec 31, 2022 | 24.64 Mn |
| Sep 30, 2022 | 16.85 Mn |
| Sep 30, 2022 | 16.85 Mn |
| Jun 30, 2022 | 9.91 Mn |
| Jun 30, 2022 | 9.91 Mn |